Inflammatory Bowel Disease Is Associated With an Increased Risk of Hospitalization for Heart Failure A Danish Nationwide Cohort Study

被引:73
作者
Kristensen, Soren Lund [1 ]
Ahlehoff, Ole [1 ,2 ]
Lindhardsen, Jesper
Erichsen, Rune [3 ]
Lamberts, Morten [1 ]
Khalid, Usman [1 ]
Nielsen, Ole Haagen [4 ]
Torp-Pedersen, Christian [5 ]
Gislason, Gunnar Hilmar [1 ,6 ]
Hansen, Peter Riis [1 ]
机构
[1] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Gentofte, Denmark
[2] Univ Copenhagen, Hosp Roskilde, Dept Cardiol, Roskilde, Denmark
[3] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
[4] Univ Copenhagen, Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark
[5] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark
[6] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark
关键词
Crohn disease; colitis; ulcerative; heart failure; inflammation; inflammatory bowel diseases; RHEUMATOID-ARTHRITIS; ATRIAL-FIBRILLATION; ATHEROSCLEROSIS; STROKE; HEALTH; GLUCOCORTICOIDS; MECHANISMS; THERAPY;
D O I
10.1161/CIRCHEARTFAILURE.114.001152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Inflammatory bowel disease (IBD) has been linked to adverse cardiovascular events, but a relation to heart failure (HF) is uncertain. We investigated the IBD-associated risk of HF in a nationwide setting. Methods and Results-A total of 5 436 647 Danish citizens, with no history of IBD or HF, were included on January 1, 1997, and followed up until first hospitalization for HF, death, or December 31, 2011. Of these subjects, 23 681 developed IBD for which disease activity was determined continuously throughout the study. The risk of hospitalization for HF was estimated with a Poisson regression model adjusting for comorbidity and cardiovascular pharmacotherapy as time-dependent covariates. During a mean follow-up of 11.8 years in the reference population and 6.4 years in the IBD group, hospitalization for HF occurred in 553 subjects with IBD and 171 405 in the reference population. Patients with IBD had a 37% increased risk of hospitalization for HF (incidence rate ratio, 1.37; 95% confidence interval, 1.26-1.49) compared with the reference population. IBD activity-specific analyses showed markedly increased risk of HF hospitalization during flares (incidence rate ratio, 2.54; 95% confidence interval, 2.13-3.04) and persistent activity (incidence rate ratio, 2.73; 95% confidence interval, 2.25-3.33) but not in IBD remission (incidence rate ratio, 1.04; 95% confidence interval, 0.94-1.16). Conclusions-In a nationwide cohort, IBD was associated with an increased risk of hospitalization for HF, and this risk was strongly correlated to periods of active disease. The mechanisms underlying this finding warrant further studies.
引用
收藏
页码:717 / U55
页数:8
相关论文
共 36 条
[1]   Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study [J].
Ahlehoff, Ole ;
Gislason, Gunnar H. ;
Jorgensen, Casper H. ;
Lindhardsen, Jesper ;
Charlot, Mette ;
Olesen, Jonas B. ;
Abildstrom, Steen Z. ;
Skov, Lone ;
Torp-Pedersen, Christian ;
Hansen, Peter Riis .
EUROPEAN HEART JOURNAL, 2012, 33 (16) :2054-2064
[2]  
Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra
[3]   Inflammatory mediators in chronic heart failure: An overview [J].
Anker, SD ;
von Haehling, S .
HEART, 2004, 90 (04) :464-470
[4]   Crohn's disease [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2012, 380 (9853) :1590-1605
[5]   Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis [J].
Bernatsky, S ;
Hudson, M ;
Suissa, S .
RHEUMATOLOGY, 2005, 44 (05) :677-680
[6]   Heart Failure-Associated Hospitalizations in the United States [J].
Blecker, Saul ;
Paul, Margaret ;
Taksler, Glen ;
Ogedegbe, Gbenga ;
Katz, Stuart .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) :1259-1267
[7]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[8]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[9]   Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system [J].
Fonager, K ;
Sorensen, HT ;
Rasmussen, SN ;
MollerPetersen, J ;
Vyberg, M .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (02) :154-159
[10]   Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study [J].
Grainge, Matthew J. ;
West, Joe ;
Card, Timothy R. .
LANCET, 2010, 375 (9715) :657-663